Skip to main content

Oncolytic HSV Exerts Direct Antiangiogenic Activity in Ovarian Carcinoma

Publication ,  Conference
Benencia, F; Courreges, MC; Conejo-Garcia, J; Buckanovich, R; Coukos, G
Published in: Journal of Immunotherapy
November 2004

Duke Scholars

Published In

Journal of Immunotherapy

DOI

ISSN

1524-9557

Publication Date

November 2004

Volume

27

Issue

6

Start / End Page

S7 / S7

Publisher

Ovid Technologies (Wolters Kluwer Health)

Related Subject Headings

  • Immunology
  • 3211 Oncology and carcinogenesis
  • 3204 Immunology
  • 1107 Immunology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Benencia, F., Courreges, M. C., Conejo-Garcia, J., Buckanovich, R., & Coukos, G. (2004). Oncolytic HSV Exerts Direct Antiangiogenic Activity in Ovarian Carcinoma. In Journal of Immunotherapy (Vol. 27, pp. S7–S7). Ovid Technologies (Wolters Kluwer Health). https://doi.org/10.1097/00002371-200411000-00029
Benencia, Fabian, Maria C. Courreges, Jose Conejo-Garcia, Ronald Buckanovich, and George Coukos. “Oncolytic HSV Exerts Direct Antiangiogenic Activity in Ovarian Carcinoma.” In Journal of Immunotherapy, 27:S7–S7. Ovid Technologies (Wolters Kluwer Health), 2004. https://doi.org/10.1097/00002371-200411000-00029.
Benencia F, Courreges MC, Conejo-Garcia J, Buckanovich R, Coukos G. Oncolytic HSV Exerts Direct Antiangiogenic Activity in Ovarian Carcinoma. In: Journal of Immunotherapy. Ovid Technologies (Wolters Kluwer Health); 2004. p. S7–S7.
Benencia, Fabian, et al. “Oncolytic HSV Exerts Direct Antiangiogenic Activity in Ovarian Carcinoma.” Journal of Immunotherapy, vol. 27, no. 6, Ovid Technologies (Wolters Kluwer Health), 2004, pp. S7–S7. Crossref, doi:10.1097/00002371-200411000-00029.
Benencia F, Courreges MC, Conejo-Garcia J, Buckanovich R, Coukos G. Oncolytic HSV Exerts Direct Antiangiogenic Activity in Ovarian Carcinoma. Journal of Immunotherapy. Ovid Technologies (Wolters Kluwer Health); 2004. p. S7–S7.

Published In

Journal of Immunotherapy

DOI

ISSN

1524-9557

Publication Date

November 2004

Volume

27

Issue

6

Start / End Page

S7 / S7

Publisher

Ovid Technologies (Wolters Kluwer Health)

Related Subject Headings

  • Immunology
  • 3211 Oncology and carcinogenesis
  • 3204 Immunology
  • 1107 Immunology